Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03756012 · ClinicalTrials.gov registry record · NA
Evaluation of Clinical Outcomes of Pulse Widths in Spinal Cord Stimulation
A NA study, sponsored by Kettering Health Network.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT03756012 is a NA study that has completed, run by Kettering Health Network. The registered enrollment target is 15 participants.
The verdict
NCT03756012, a NA study, has completed, sponsored by Kettering Health Network.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effect of pulse widths \<500 μsec and \>1000 μsec on clinical outcomes during a temporary SCS trial.
Interventions
- DEVICE Algovita Spinal Cord Stimulation System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2018-11-27 |
| Est. Completion | 2019-10-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03756012
The ClinicalTrials.gov registry entry for NCT03756012 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kettering Health Network, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Algovita Spinal Cord Stimulation System is the first listed.
NCT03756012 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03756012 about?
NCT03756012 is a clinical study titled "Evaluation of Clinical Outcomes of Pulse Widths in Spinal Cord Stimulation". The purpose of this study is to evaluate the effect of pulse widths \<500 μsec and \>1000 μsec on clinical outcomes during a temporary SCS trial.
What is the current status of trial NCT03756012?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2018-11-27. Estimated completion is 2019-10-02.
What interventions are being tested in trial NCT03756012?
The interventions under investigation include: Algovita Spinal Cord Stimulation System (DEVICE).
Who is sponsoring clinical trial NCT03756012?
This trial is sponsored by Kettering Health Network, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.